Reply to ‘Re: Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy’-Reference-Cited by-同舟云学术

Reply to ‘Re: Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy’

Published:2024-02-28 Issue:S4 Volume:133 Page:25-26
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Geboers Bart¹²³^ORCID,Scheltema Matthijs J.V.¹²⁴^ORCID,Emmett Louise¹⁵,Stricker Phillip D.¹²^ORCID

Affiliation:

1. Garvan Institute of Medical Research and The Kinghorn Cancer Centre Sydney New South Wales Australia

2. St. Vincent's Prostate Cancer Research Centre Sydney New South Wales Australia

3. Department of Radiology and Nuclear Medicine Amsterdam UMC (location VUmc) Amsterdam The Netherlands

4. Department of Urology St. Antonius Hospital Nieuwegein The Netherlands

5. Department of Theranostics and Nuclear Medicine St. Vincent's, Hospital Sydney New South Wales Australia

Publisher

Wiley

Reference5 articles.

1. Re: ‘Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy’

2. Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy

3. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

4. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort

5. Multiparametric Magnetic Resonance Imaging Guided Diagnostic Biopsy Detects Significant Prostate Cancer and could Reduce Unnecessary Biopsies and Over Detection: A Prospective Study